Stay updated with breaking news from Compass Pathways. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Explore the potential of psilocybin therapy for treating mental health conditions like depression, anxiety, and substance use disorders. Learn about its history, how it works, benefits, risks, and more.
By Faith Ashmore, BenzingaTreatment-resistant depression, also referred to as TRD, is a subset of depression that poses significant challenges for clinicians, patients and those closest to patients....
Shares of COMPASS Pathways plc (NASDAQ:CMPS – Get Free Report) have been assigned an average recommendation of “Buy” from the six brokerages that are currently covering the stock, Marketbeat Ratings reports. Six investment analysts have rated the stock with a buy recommendation. The average twelve-month target price among brokerages that have covered the stock in […]
Treatment-resistant depression, also referred to as TRD, is a subset of depression that poses significant challenges for clinicians, patients and those closest to patients. It is characterized by persistent symptoms of depression that do not respond adequately to at least two different standard antidepressant treatments.
Could a single tablet help improve the outcome for patients with anorexia? That is the tantalising prospect offered by a study published in August looking at the use of psilocybin, the hallucinogenic component of magic mushrooms.